Literature DB >> 9240765

Obesity and the insulin resistance syndrome.

L Landsberg1.   

Abstract

Obesity is one component of a risk factor constellation that consists of insulin resistance (and/or hyperinsulinemia), hypertension, and a dyslipidemia characterized by a low HDL cholesterol level and high triglyceride levels. This risk factor constellation, which conveys enhanced risk for cardiovascular disease, is sometimes referred to as the "insulin resistance syndrome", "syndrome x", or the "metabolic" syndrome. Although the hyperinsulinemia and insulin resistance associated with the syndrome appear to play a central role, the relationship between insulin and the other manifestations of the syndrome have remained obscure.

Entities:  

Mesh:

Year:  1996        PMID: 9240765     DOI: 10.1291/hypres.19.supplementi_s51

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

Review 1.  Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

2.  Comparison of EQ-5D-3L and metabolic components between patients with hyperhidrosis and the general population: a propensity score matching analysis.

Authors:  Yea-Chan Lee; Young Kyung You; Jun Hyuk Lee; Duk Hwan Moon; Sungsoo Lee; Soyoung Jeon; Hye Sun Lee; Ji-Won Lee
Journal:  Qual Life Res       Date:  2021-05-11       Impact factor: 4.147

Review 3.  Carotid body, insulin, and metabolic diseases: unraveling the links.

Authors:  Sílvia V Conde; Joana F Sacramento; Maria P Guarino; Constancio Gonzalez; Ana Obeso; Lucilia N Diogo; Emilia C Monteiro; Maria J Ribeiro
Journal:  Front Physiol       Date:  2014-10-29       Impact factor: 4.566

4.  Neuronal and Endothelial Nitric Oxide Synthases in the Paraventricular Nucleus Modulate Sympathetic Overdrive in Insulin-Resistant Rats.

Authors:  Qing-Bo Lu; Xue-Mei Feng; Ning Tong; Hai-Jian Sun; Lei Ding; Yu-Jiao Wang; Xuan Wang; Ye-Bo Zhou
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

5.  Muscle Sympathetic Nerve Activity Is Associated with Liver Insulin Sensitivity in Obese Non-Diabetic Men.

Authors:  Daniel L T Chen; Rachael Brown; Carsten Liess; Anne Poljak; Aimin Xu; Jialiang Zhang; Michael Trenell; Arthur Jenkins; Donald Chisholm; Dorit Samocha-Bonet; Vaughan G Macefield; Jerry R Greenfield
Journal:  Front Physiol       Date:  2017-02-28       Impact factor: 4.566

Review 6.  Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity.

Authors:  Maria Paola Canale; Simone Manca di Villahermosa; Giuliana Martino; Valentina Rovella; Annalisa Noce; Antonino De Lorenzo; Nicola Di Daniele
Journal:  Int J Endocrinol       Date:  2013-10-31       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.